Delivery Order SPE2DB20D2104-SPE2DB25FMXMV
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,197.66 to AmerisourceBergen Drug Corp on August 9, 2025, with completion scheduled for August 11, 2025. This firm fixed-price, non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $386,479.07 to AmerisourceBergen Drug Corp on July 21, 2025, for pharmaceutical and medical supply distribution. This firm fixed-price, non-set-aside contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,030.52 to AmerisourceBergen Drug Corp on August 5, 2025, with completion scheduled for August 6, 2025. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion prime vendor agreement running through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $366,047.12 to AmerisourceBergen Drug Corp on August 16, 2025, for pharmaceutical products and medical supplies. This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 18, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,447.93 to AmerisourceBergen Drug Corp on July 28, 2025, for pharmaceutical and medical supply products. This firm fixed-price, non-set-aside contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,167.54 to AmerisourceBergen Drug Corp on September 8, 2025, for pharmaceutical products under a firm fixed-price contract. This competitively awarded delivery order, with an ultimate completion date of September 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,391.80 to AmerisourceBergen Drug Corp on June 16, 2025, for pharmaceutical products and medical supplies. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,684.19 to AmerisourceBergen Drug Corp on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction for pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,060.18 to AmerisourceBergen Drug Corp on July 28, 2025, for pharmaceutical and medical supply fulfillment. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,267.90 to AmerisourceBergen Drug Corp on August 16, 2025, for pharmaceutical and medical supply delivery. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. The award was made through open...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXMVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,916.19 to AmerisourceBergen Drug Corp on August 14, 2025, for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued under a non-competitive, non-set-aside procurement, is scheduled for completion by August 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. Through its DLA IDC, the company supplies an extensive portfolio of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialty healthcare commodities across multiple therapeutic domains. The company's federal contract awards demonstrate its capability to fulfill diverse medical supply needs across a wide range of transaction values, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order represents routine pharmaceutical procurement operations under the established prime vendor relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/14/25 |